vs
Side-by-side financial comparison of Howard Hughes Holdings Inc. (HHH) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $235.9M, roughly 4.7× Howard Hughes Holdings Inc.). Howard Hughes Holdings Inc. runs the higher net margin — 3.4% vs -127.8%, a 131.2% gap on every dollar of revenue. On growth, Howard Hughes Holdings Inc. posted the faster year-over-year revenue change (18.4% vs -2.5%). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -13.8%).
Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
HHH vs PRGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $235.9M | $1.1B |
| Net Profit | $8.1M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 121.6% | -116.0% |
| Net Margin | 3.4% | -127.8% |
| Revenue YoY | 18.4% | -2.5% |
| Net Profit YoY | -25.6% | -3093.9% |
| EPS (diluted) | $0.14 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $235.9M | — | ||
| Q4 25 | $624.4M | $1.1B | ||
| Q3 25 | $390.2M | $1.0B | ||
| Q2 25 | $260.9M | $1.1B | ||
| Q1 25 | $199.3M | $1.0B | ||
| Q4 24 | $935.0M | $1.1B | ||
| Q3 24 | $327.1M | $1.1B | ||
| Q2 24 | $317.4M | $1.1B |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $6.0M | $-1.4B | ||
| Q3 25 | $119.5M | $7.5M | ||
| Q2 25 | $-12.1M | $-8.4M | ||
| Q1 25 | $10.5M | $-6.4M | ||
| Q4 24 | $156.3M | $-44.4M | ||
| Q3 24 | $72.8M | $-21.0M | ||
| Q2 24 | $21.1M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% |
| Q1 26 | 121.6% | — | ||
| Q4 25 | 4.2% | -116.0% | ||
| Q3 25 | 48.6% | 7.0% | ||
| Q2 25 | 26.0% | 4.3% | ||
| Q1 25 | 24.0% | 4.5% | ||
| Q4 24 | 33.5% | 10.0% | ||
| Q3 24 | 60.6% | 7.4% | ||
| Q2 24 | 20.4% | -2.5% |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 1.0% | -127.8% | ||
| Q3 25 | 30.6% | 0.7% | ||
| Q2 25 | -4.7% | -0.8% | ||
| Q1 25 | 5.3% | -0.6% | ||
| Q4 24 | 16.7% | -3.9% | ||
| Q3 24 | 22.2% | -1.9% | ||
| Q2 24 | 6.6% | -10.2% |
| Q1 26 | $0.14 | — | ||
| Q4 25 | $0.20 | $-10.23 | ||
| Q3 25 | $2.02 | $0.05 | ||
| Q2 25 | $-0.22 | $-0.06 | ||
| Q1 25 | $0.21 | $-0.05 | ||
| Q4 24 | $3.14 | $-0.32 | ||
| Q3 24 | $1.46 | $-0.15 | ||
| Q2 24 | $0.42 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.8B | $2.9B |
| Total Assets | $11.2B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $432.1M | ||
| Q2 25 | $1.4B | $454.2M | ||
| Q1 25 | $493.7M | $409.9M | ||
| Q4 24 | $596.1M | $558.8M | ||
| Q3 24 | $400.7M | $1.5B | ||
| Q2 24 | $436.8M | $542.8M |
| Q1 26 | — | — | ||
| Q4 25 | $5.1B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.8B | — | ||
| Q4 25 | $3.8B | $2.9B | ||
| Q3 25 | $3.8B | $4.4B | ||
| Q2 25 | $3.6B | $4.5B | ||
| Q1 25 | $2.8B | $4.4B | ||
| Q4 24 | $2.8B | $4.3B | ||
| Q3 24 | $2.6B | $4.6B | ||
| Q2 24 | $3.0B | $4.5B |
| Q1 26 | $11.2B | — | ||
| Q4 25 | $10.6B | $8.5B | ||
| Q3 25 | $10.7B | $10.1B | ||
| Q2 25 | $10.3B | $10.1B | ||
| Q1 25 | $9.3B | $9.8B | ||
| Q4 24 | $9.2B | $9.6B | ||
| Q3 24 | $9.4B | $11.2B | ||
| Q2 24 | $9.9B | $10.4B |
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $360.3M | $175.4M | ||
| Q3 25 | $149.8M | $51.7M | ||
| Q2 25 | $177.3M | $75.9M | ||
| Q1 25 | $-224.9M | $-64.5M | ||
| Q4 24 | $337.1M | $312.6M | ||
| Q3 24 | $248.3M | $42.2M | ||
| Q2 24 | $-17.5M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | $348.6M | $148.6M | ||
| Q3 25 | $137.7M | $29.8M | ||
| Q2 25 | $169.7M | $56.7M | ||
| Q1 25 | $-238.4M | $-90.0M | ||
| Q4 24 | $317.1M | $274.9M | ||
| Q3 24 | $238.7M | $15.1M | ||
| Q2 24 | $-25.1M | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | 55.8% | 13.4% | ||
| Q3 25 | 35.3% | 2.9% | ||
| Q2 25 | 65.1% | 5.4% | ||
| Q1 25 | -119.6% | -8.6% | ||
| Q4 24 | 33.9% | 24.2% | ||
| Q3 24 | 73.0% | 1.4% | ||
| Q2 24 | -7.9% | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 2.4% | ||
| Q3 25 | 3.1% | 2.1% | ||
| Q2 25 | 2.9% | 1.8% | ||
| Q1 25 | 6.8% | 2.4% | ||
| Q4 24 | 2.1% | 3.3% | ||
| Q3 24 | 2.9% | 2.5% | ||
| Q2 24 | 2.4% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 60.04× | — | ||
| Q3 25 | 1.25× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | -21.35× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 3.41× | — | ||
| Q2 24 | -0.83× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHH
| Rental revenue | $113.5M | 48% |
| Master Planned Communities land sales | $99.6M | 42% |
| Other revenues | $11.0M | 5% |
| Builder price participation | $8.7M | 4% |
| Condominium rights and unit sales | $3.1M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
